Aggressive NK-cell leukemia epidemiology and demographics

Revision as of 14:16, 14 August 2015 by Parminder Dhingra (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Aggressive NK-cell leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aggressive NK-cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aggressive NK-cell leukemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aggressive NK-cell leukemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aggressive NK-cell leukemia epidemiology and demographics

CDC on Aggressive NK-cell leukemia epidemiology and demographics

Aggressive NK-cell leukemia epidemiology and demographics in the news

Blogs on Aggressive NK-cell leukemia epidemiology and demographics

Directions to Hospitals Treating Aggressive NK-cell leukemia

Risk calculators and risk factors for Aggressive NK-cell leukemia epidemiology and demographics

Epidemiology

This rare form a leukemia is more common among Asians in comparison to other ethnic groups. It is typically diagnosed in adolescents and young adults, with a slight predominance in males.[1][2][3][4]

References

  1. [1] Kwong YL, Wong KF, Chan LC, Liang RH, Chan JK, Lin CK, Chan TK. "Large granular lymphocyte leukemia. A study of nine cases in a Chinese population." Am J Clin Pathol. 1995 Jan;103(1):76-81. PMID: 7817949
  2. [2] Kwong YL, Chan AC, Liang RH. "Natural killer cell lymphoma/leukemia: pathology and treatment." Hematol Oncol. 1997 May;15(2):71-9. PMID: 9375032
  3. [3] Gelb AB, van de Rijn M, Regula DP Jr, Cornbleet JP, Kamel OW, Horoupian DS, Cleary ML, Warnke RA. "Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia." Hum Pathol. 1994 Sep;25(9):953-60. PMID: 8088773
  4. [4] Oshimi K. "Lymphoproliferative disorders of natural killer cells." Int J Hematol. 1996 Jun;63(4):279-90. PMID: 8762811